Implementation of a lifestyle-based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer

R. Bultijnck, A. Bruggeman, B. Van Ruymbeke, S. Mortier, A. Raes, E. Rammant, M. De Muynck, B. Deforche, V. Fonteyne, K. Decastecker, N. Lumen, P. Ost

Research output: Contribution to journalConference paper

Abstract

Aim: To assess the effect of a lifestyle-based prostate cancer pathway, incorporated in daily practice, to increase the implementation of evidence-based strategies to manage ADT-induced side effects. Methods: PCa patients receiving ADT for >6 months were referred to the pathway (ie as standard practice), through a central coordinator. The pathway consisted of a medical screening (ie bone and cardiometabolic screening) and a rehabilitation program with a supervised exercise program (3 months) and referrals to a dietician and a psychologist. Anthropometric parameters and physical performance were measured at baseline and after 3 months. Primary endpoint was physical performance evaluated with the 400-m walk test. Planned referral target was set at 200 to accomplish a sample size of 120 patients following the exercise program. A meaningful clinically important difference of the 400-m testwas defined as 17 s improvement and P < .05 was considered statistically significant. Results: Between January 2015 and June 2018, 200 patients were referred to the pathway, of which 177 were enrolled (median age 69, IQR 63-74). The majority (84%) had a good functional status (Karnofsky Performance ≥90) at baseline. The indication for ADT was curative in combination with local therapy for locally advanced PCa in 67% and palliative for (non)metastatic PCa in 33% of patients. In total, 124 followed the complete pathway. Medical screening indicated a lower bone mineral density in 51% of the patients and 25% had metabolic syndrome. After initial referral, 43% choose to receive diet advice and 64% psycho-education. A clinically meaningful performance improvement was observed in patients following the exercise program (282 to 253 s; P < .001). Compliance rate of the exercise program was high (83%). A total of 10% dropped-out due to medical reasons. After the 3-month exercise program, 81% voluntary continued. Conclusion: Physical performance improved after following a lifestylebased clinical pathway for prostate cancer patients in daily practice.
Original languageEnglish
Number of pages2
JournalAsia-Pacific Journal of Clinical Oncology
Volume15
Issue numberSUPPL 9
DOIs
Publication statusPublished - 2019
Externally publishedYes

Bibliographical note

M1 - (Bultijnck R.; Rammant E.; Fonteyne V.; Decastecker K.; Lumen N.; Ost P.) Department of Human Structure and Repair, Ghent University, Ghent, Belgium

M1 - (Bultijnck R.; Ost P.) Research Foundation - Flanders (FWO), Brussels, Belgium

M1 - (Bruggeman A.; Van Ruymbeke B.; De Muynck M.) Department of Physical and Rehabilitation Medicine, Ghent University Hospital, Ghent, Belgium

M1 - (Mortier S.; Raes A.) Cancer Center, Ghent University Hospital, Ghent, Belgium

M1 - (Deforche B.) Department of Public Health and Primary Care, Ghent University, Ghent, Belgium

M1 - (Deforche B.) Department of Physical Activity, Nutrition and Health, Vrije Universiteit Brussel, Brussels, Belgium

Keywords

  • advanced cancer
  • aged
  • androgen deprivation therapy
  • anthropometric parameters
  • bone density
  • cancer patient
  • clinical practice
  • conference abstract
  • controlled study
  • diet
  • dietitian
  • exercise
  • functional status
  • human
  • human tissue
  • lifestyle
  • local therapy
  • major clinical study
  • male
  • metabolic syndrome X
  • patient referral
  • physical performance
  • prostate cancer
  • psychoeducation
  • psychologist
  • rehabilitation
  • sample size
  • side effect
  • walk test

Fingerprint

Dive into the research topics of 'Implementation of a lifestyle-based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer'. Together they form a unique fingerprint.

Cite this